APY
Annual percentage yield (APY) is a normalized representation of an interest rate, based on a compounding period of one year. APY figures allow a reasonable, single-point comparison of different offerings with varying compounding schedules. However, it does not account for the possibility of account fees affecting the net gain. APY generally refers to the rate paid to a depositor by a financial institution, while the analogous annual percentage rate (APR) refers to the rate paid to a financial institution by a borrower.
Beyond's analysis on APY
- — Certificate of Deposit (CD) rates hold steady at 4.40% APY as investors seek stable returns
- — US banks are offering up to 4.40% APY on 2‑year CDs, signaling attractive yields for savers amid a steady interest‑rate environment
- — Retail deposit rates climb to 4.35% APY for 18‑month CDs, signaling stronger bank funding costs
- — Top CD yields hit 4.30% APY as savers chase higher returns amid stable short‑term rates
- — U.S. banks are offering up to 4.30% APY on 16‑ or 18‑month CDs, reflecting elevated short‑term interest rates
- — Top CD yields hit 4.35% APY, offering savers a high‑return option amid steady rates
- — Top-yielding certificates of deposit now offer 4.35% APY, reflecting elevated short-term interest rates
- — Top CD rates hit 4.30% APY, offering savers a competitive fixed‑income yield
- — CD rates hold steady at 4.30% APY, reflecting stable short‑term deposit yields
- — The rise to 4.30% APY for top CD accounts signals a more attractive yield environment for savers and higher funding costs for banks
- — CD rates climb to 4.35% APY amid rising savings yields
- — Top CD yields hold steady at 4.15% APY amid stable short-term savings demand
Recent news mentioning APY
- — International Researchers Convene in Oslo to Set the First Consensus Standards for Heat Therapy Research
- — Apertura Gene Therapy to Provide Lexeo Therapeutics Access to TfR1 CapX™ for Program Designed to Treat Friedreich Ataxia
- — BoomRay and Novartis Pharma sign $900m deal for radioligand therapy
- — Best CD rates today, Wednesday, September 23, 2026: Earn up to 4.40% APY with Happen Bank
- — Physical Therapy Expert Paul Dye Discusses How Dry Needling Supports Rehabilitation in HelloNation
- — Myrava Advances Personalized Radiation Therapy With FDA 510(k) Clearance for Patient-Specific 3D Printed Bolus Device
- — Best CD rates today, Tuesday, September 22, 2026: Lock in up to 4.40% APY
- — BoomRay Enters Exclusive Global License Agreement with Novartis for a Novel Radioligand Therapy Asset
- — PTC Completes Acquisition of ST-920 Fabry Disease Gene Therapy
- — VETS Celebrates Governor Newsom's Signing of AB 113, Delivering California's First-Ever State Investment in Veteran Psychedelic-Assisted Therapy Research
- — ResMed Targets 12%-14% EPS Growth as GLP-1 Patients Lift Sleep Therapy Demand
- — Cell Therapy Manufacturer Buys 85K SF Facility To Expand In Philly Suburbs